Role of the Maternal Gut Microbiota in Immune Activation at the Maternal Foetal...
Role of the Maternal Gut Microbiota in Immune Activation at the Maternal Foetal Interface Impact on Preeclampsia and Offspring s Immune Development
Preeclampsia is a leading cause of morbidity and mortality in pregnancy. Although the pathogenesis remains largely elusive, it is thought to reside in loss of immune-tolerance at the maternal-foetal interface. At present, preeclam...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
MICROBIOTA-NEONATE
Characterization of maternal microbiota dependent imprinting...
199K€
Cerrado
MEMORIS
Maternal Enteric Microbiota for Offspring s Repertoire devel...
187K€
Cerrado
AGL2010-15420
APLICACION DE TECNICAS -OMICAS PARA EVALUAR LOS EFECTOS DE P...
289K€
Cerrado
ProLung
The role of maternal microbiota in offspring lung developmen...
212K€
Cerrado
FJC2018-035861-I
El microbioma materno-infantil y reproductivo y su modulació...
50K€
Cerrado
HHMM-Neonates
DEVELOPMENT OF HEALTHY HOST MICROBIAL MUTUALISM IN EARLY LIF...
3M€
Cerrado
Información proyecto DaPhNIs
Duración del proyecto: 30 meses
Fecha Inicio: 2018-12-17
Fecha Fin: 2021-07-15
Líder del proyecto
HUMANITAS MIRASOLE SPA
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
168K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Preeclampsia is a leading cause of morbidity and mortality in pregnancy. Although the pathogenesis remains largely elusive, it is thought to reside in loss of immune-tolerance at the maternal-foetal interface. At present, preeclampsia can neither be reliably predicted nor prevented.
Scope of this research project is to investigate how changes in microbiota during pregnancy impact immune responses at the maternal-foetal interface, and to determine the consequences on pregnancy outcomes as well as development of offspring’s immunity. Translational relevance of findings specifically to preeclampsia will be evaluated in a large cohort of patients, with implications potentially arising from the identification of novel biomarkers and of molecular mechanisms amenable to pharmacologic intervention.
The Experienced Researcher (ER) of this study, Dr. Silvia Giugliano, is an accomplished immunologist with primary expertise in organ-specific immune responses to microbes. Formerly an independent academic researcher in the USA, she was recently recruited to work at the European Institute of Oncology (Milan, Italy) by Prof. Maria Rescigno, a world-class expert in the field of microbiota and mucosal immunity, specifically to advance the hosting laboratory’s expertise in placental immunity.
There is an urgent call for actions aimed at improving women’s health, and it is incumbent on the scientific community to tackle this issue. Thus, the present proposal captures the current zeitgeist and social responsibility of Science. Complementary, prime expertise between the ER and host laboratory will create a synergistic enterprise, ideally suited to the pursuit of this ambitious research goal. Findings and hypotheses generated in this process will kick off additional, related projects, and will be disseminated beyond the boundaries of the scientific community and to public audiences. The ER will emerge with new skills, and the capability to transition to independence in her home country.